Abstract
The TDE supplement (41:1S), titled “Management of the Complex Pathophysiology of Diabetes: Focus on Noninsulin Therapies,” which accompanied the December 2015 issue of TDE, had an incorrect disclaimer. The disclaimer should have read as follows: “This supplement was supported by AstraZeneca.”
Get full access to this article
View all access options for this article.